Abstract
To explore the prevalence of and risk factors for erectile dysfunction (ED) in Iran. A total of 2674 men aged 20–70 y old were interviewed by 42 general practitioners and answered a self-administered questionnaire. The subjects were randomly identified from 28 counties of Iran. ED was defined as difficulties in achieving an erection before sexual intercourse and maintaining it. Data on medical history, toxic habits, and current use of medications were also obtained. Of the men interviewed, 18.8% (460) reported ED. Impotence was found to be significantly associated with age and was less associated with geographical location. The prevalence increased with age, from 6% in men 20–39 y to 47% in those >60 y (tested for trend P<0.001). A history of diabetes (odds ratio (OR) 3.72, 95% confidence interval (CI), 2.51–5.71), hypertension (OR 1.69, 95% CI, 1.31–2.40), peripheral vascular disorders (OR 2.44, 95% CI, 1.65–3.74), hypercholesterolemia (OR 1.71, 95% CI, 1.11–2.65), and coronary artery disease (OR 1.61, 95% CI, 1.21–2.85) were significantly associated with ED. In comparison with never smokers, the OR of ED was 2.41 (95% CI, 1.52–3.30) for current smokers and 2.15 (95% CI, 1.38–3.1) for exsmokers and increased with duration of the habit. Drug intake, called tranquilizers and antidepressants, correlated strongly (OR 3.71, 95% CI, 2.51–6.76 and OR 2.80, 95% CI, 1.47–4.32, respectively). This study provides a quantitative estimate of the prevalence and main risk factors for ED in Iranian men.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 8 print issues and online access
$259.00 per year
only $32.38 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
NIH Consensus Conference: Impotence. NIH Consensus Development Panel on Impotence. JAMA 1993; 270: 83–90.
Benet AE, Melman A . The epidemiology of erectile dysfunction. Urol Clin North Am 1995; 22: 699–709.
Laumann EO, Gagnon JH, Michael RT, Michaels S . The Social Organization of Sexuality: Sexual Practices in the United States. University of Chicago Press: Chicago, Ill, 1994.
Feldman HA et al. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol 1994; 151: 54–61.
Glasser D, Sweeney M . The prevalence of erectile dysfunction in four countries: Italy, Brazil, Malaysia, and Japan. Cross-National Study Group. Presented at International Consultation on Erectile Dysfunction, Paris, France, July 1–3, 1999.
Simons JS, Carey MP . Prevalence of sexual dysfunction: results from a decade of research. Arch Sex Behav 2001; 30: 177–219.
Bortolotti A, Parazzini F, Colli E, Londoni M . The epidemiology of erectile dysfunction and its risk factors. Int J Androl 1997; 20: 323–334.
Bosch JL et al. Erectile dysfunction in a community-based sample of men aged 50–75 years: prevalence and somatic and social risk factors. Eur J Urol 1999; 35: (suppl 2): 262–269.
Koskimäki J, Hakama M, Huhtala H, Tammela TLJ . Effect of erectile dysfunction on frequency of intercourse; a population based prevalence study in Finland. J Urol 2000; 164: 367–370.
Giuliano F et al. Prevalence of erectile dysfunction in France: results of epidemiological survey of a representative sample of men. Eur Urol 2002; 42: 382–389.
Akkus E et al. Prevalence and correlates of erectile dysfunction in Turkey: a population-based study. Eur Urol 2002; 41: 298–304.
Moreira JR ED et al. Prevalence and correlates of erectile dysfunction: results of the Brazilian study of sexual behavior. Urology 2001; 58: 583–588.
Mak R, De Backer G, Kornizer M, De Meyer JM . Prevalence and correlates of erectile dysfunction in a population-based study in Belgium. Eur Urol 2002; 41: 132–138.
Parazzini F et al. Frequency and determinants of erectile dysfunction in Italy. Eur Urol 2000; 37: 43–49.
Morales AM et al. Prevalence and independent risk factors for erectile dysfunction in Spain: results of the epidemiologia de la disfuncion erectil masculina study. J Urol 2001; 166: 569–575.
Johannes CB et al. Incidence of erectile dysfunction in men 40 to 69 years old: longitudinal results from the Massachusetts male aging study. J Urol 2000; 163: 460–463.
Diokno AC, Brown MB, Hergoz AR . Sexual function in the elderly. Arch Intern Med 1990; 150: 197–200.
Condra M et al. Prevalence and significance of tobacco smoking in impotence. Urology 1986; 27: 495–499.
Lauman EO, Paik A, Rosen RC . Sexual dysfunction in the United States: prevalence and predictors. JAMA 1999; 281: 537–544.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Safarinejad, M. Prevalence and risk factors for erectile dysfunction in a population-based study in Iran. Int J Impot Res 15, 246–252 (2003). https://doi.org/10.1038/sj.ijir.3901024
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.ijir.3901024